Melasma Update

Actas Dermo-Sifiliograficas

Volumn 100, Issue SUPPL. 2, 2009, Pages 110-113

  Young Kang, H ^a   Ortonne, J P ^b  

^a Ajou University School of Medicine   (South Korea)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

histology; melasma; pathogenesis; treatment

Indexed keywords

MELANIN; SEX HORMONE;

ARTICLE; CHLOASMA; HISTOPATHOLOGY; HUMAN; MELANOCYTE; SKIN PIGMENTATION; SKIN STRUCTURE;

HUMANS; MELANOSIS;

EID: 76749087524     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S0001-7310(09)73385-X     Document Type: Article

References (19)

1. Kang W.H., Yoon K.H., Lee E.S., Kim J., Lee K.B., Yim H., Sohn S., and Im S. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol 146 (2002) 228-237
2. Grimes P.E., Yamada N., and Bhawan J. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma. Am J Dermatopathol 27 (2005) 96-101
3. Sarvjot V., Sharma S., Mishra S., and Singh A. Melasma: a clinicopathological study of 43 cases. Indian J Pathol Microbiol 52 (2009) 357-359
4. Sánchez N.P., Pathak M.A., Sato S., Fitzpatrick T.B., Sánchez J.L., and Mihm Jr. M.C. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 4 (1981) 698-710
5. Ortonne J.P., Arellano I., Berneburg M., Cestari T., Chan H., Grimes P., et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol 23 (2009) 1254-1262
6. Hernández-Barrera R., Torres-Álvarez B., Castanedo-Cazares J.P., Oros-Ovalle C., and Moncada B. Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma. Clin Exp Dermatol 33 (2008) 305-308
7. Im S., Kim J., On W.Y., and Kang W.H. Increased expression of alpha-melanocyte-stimulating hormone in the lesional skin of melasma. Br J Dermatol 146 (2002) 165-167
8. Kang H.Y., Hwang J.S., Lee J.Y., Ahn J.H., Kim J.Y., Lee E.S., and Kang W.H. The dermal stem cell factor and c-kit are overexpressed in melasma. Br J Dermatol 154 (2006) 1094-1099
9. Kim E.H., Kim Y.C., Lee E.S., and Kang H.Y. The vascular characteristics of melasma. J Dermatol Sci 46 (2007) 111-116
10. Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 17 (2004) 96-110
11. Suzuki I., Kato T., Motokawa T., Tomita Y., Nakamura E., and Katagiri T. Increase of pro opiomelanocortin mRNA prior to tyrosinase, tyrosinase-related protein 1, dopachrome tautomerase, Pmel-17/gp100, and P-protein mRNA in human skin after ultraviolet B irradiation. J Invest Dermatol 118 (2002) 73-78
12. Kim E.J., Park H.Y., Yaar M., and Gilchrest B.A. Modulation of vascular endothelial growth factor receptors in melanocytes. Exp Dermatol 14 (2005) 625-633
13. Jo H.Y., Kim C.K., Suh I.B., Ryu S.W., Ha K.S., Kwon Y.G., et al. Co-localization of inducible nitric oxide synthase and phosphorylated Akt in the lesional skins of patients with melasma. J Dermatol 36 (2009) 10-16
14. Hexsel D., Rodrigues T., Dal'Forno T., Zechmeister-Prado D., and Lima M. Melasma and pregnancy in southern Brazil. J Eur Acad Dermatol Venereol 23 (2008) 367-368
15. Moin A., Jabery Z., and Fallah N. Prevalence and awareness of melasma during pregnancy. Int J Dermatol 45 (2006) 285-288
16. Pérez M., Sánchez J.L., and Aguiló F. Endocrinologic profile of patients with idiopathic melasma. J Invest Dermatol 81 (1983) 543-545
17. Jee S.H., Lee S.Y., Chiu H.C., Chang C.C., and Chen T.J. Effects of estrogen and estrogen receptor in normal human melano cytes. Biochem Biophys Res Commun 199 (1994) 1407-1412
18. Kippenberger S., Loitsch S., Solano F., Bernd A., and Kaufmann R. Quantification of tyrosinase, TRP-1, and Trp-2 transcripts in human melanocytes by reverse transcriptase-competitive multiplex PCR-regulation by steroid hormones. J Invest Dermatol 110 (1998) 364-367
19. Lieberman R., and Moy L. Estrogen receptor expression in melasma: results from facial skin of affected patients. J Drugs Dermatol 7 (2008) 463-465